Please use this identifier to cite or link to this item: doi:10.22028/D291-45993
Title: Identification and heterologous expression of an NRPS biosynthetic gene cluster responsible for the production of the pyrazinones Ichizinone A, B and C
Author(s): Oberhäuser, Patrick
Myronovskyi, Maksym
Stierhof, Marc
Gromyko, Oleksandr
Luzhetskyy, Andriy
Language: English
Title: Microbial Cell Factories
Volume: 24
Issue: 1
Publisher/Platform: BMC
Year of Publication: 2025
Free key words: Actinobacteria
Streptomyces
Pyrazinone
NRPS
Heterologous expression
Gene cluster
Biosynthesis
DDC notations: 500 Science
Publikation type: Journal Article
Abstract: Pyrazinones are a growing family of microbial NRPS-derived natural products showing interesting biological activities. These compounds are characterized by the presence of either a di- or trisubstituted heterocyclic, nonaromatic 2(1 H)-pyrazinone core in their structure. The most commonly occurring disubstituted pyrazinone natural products are synthesized through a dipeptide intermediate, which is further cyclized to yield the pyrazinone moiety. Trisubstituted pyrazinones are seldom found in natural products, with JBIR56 and JBIR57, isolated from marine Streptomyces, being notable examples. In contrast to the simply organized disubstituted pyrazinones, JBIR56 and JBIR57 are syn-thesized as tetrapeptides with unnatural beta-amino acid residue involved in the for-mation of the pyrazinone moiety. Despite interesting structural features, biosynthetic routes leading to the production of these compounds have not been reported yet. Here we report the discovery of new members of trisubstituted pyrazinone family– tetrapeptides ichizinones A-C in Streptomyces sp. LV45-129. Through sequence analysis and heterologous expression, a biosynthetic gene cluster encoding ichizinone production was identified. Based on gene annotation and sequence homology, a biosynthetic model was suggested. The presented results provide insights into the biosynthesis of rare trisubstituted pyrazinone natural products.
DOI of the first publication: 10.1186/s12934-025-02753-6
URL of the first publication: https://doi.org/10.1186/s12934-025-02753-6
Link to this record: urn:nbn:de:bsz:291--ds-459938
hdl:20.500.11880/40363
http://dx.doi.org/10.22028/D291-45993
ISSN: 1475-2859
Date of registration: 8-Aug-2025
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1186%2Fs12934-025-02753-6/MediaObjects/12934_2025_2753_MOESM1_ESM.docx
Faculty: NT - Naturwissenschaftlich- Technische Fakultät
Department: NT - Pharmazie
Professorship: NT - Prof. Dr. Andriy Luzhetskyy
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s12934-025-02753-6.pdf2,06 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons